Form 4: DBV Technologies CMO Sells Shares for Tax Obligations

DBV Technologies' Chief Medical Officer, Pharis Mohideen, sold 464 ordinary shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Chief Medical Officer Pharis Mohideen of DBV Technologies S.A. (DBVT) reported a transaction on July 29, 2025.
• Mohideen sold 464 ordinary shares at a price of $2.22 per share.
• The sale was conducted to satisfy withholding tax obligations upon the vesting of restricted stock units.
• Following this transaction, Mohideen beneficially owns 109,649 ordinary shares.
• Ordinary shares may be represented by American Depositary Shares (ADS), where each ADS currently represents five ordinary shares.
• The sale price of $2.22 USD reflects a conversion from EURO at an exchange rate of $1.1549 to EURO 1.00 as of July 29, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares by an officer to cover tax obligations upon the vesting of restricted stock units, which is a common and expected event and does not reflect a discretionary sale or change in sentiment towards the company.

Negatives

• Chief Medical Officer Pharis Mohideen disposed of 464 ordinary shares, reducing his direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal impact on shareholders as it's a small, non-discretionary sale for tax purposes.

Key Dates

Recommendation

The reported transaction is a non-discretionary sale of a small number of shares by a Chief Medical Officer solely to satisfy tax withholding obligations upon the vesting of restricted stock units. This is a common and expected event for executive compensation and does not indicate any change in the company's fundamentals or the officer's long-term view. Therefore, it does not warrant a change in investment recommendation based on this filing alone.

Keywords

DBV Technologies, DBVT, Form 4, Insider Trading, Share Sale, Chief Medical Officer, Restricted Stock Units, Tax Obligations